Stock 300937 SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Equities

300937

CNE100004CV9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
22.64 CNY -0.75% Intraday chart for Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. -6.10% -28.01%
04-24 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 4,358 2,761 3,009
Enterprise Value (EV) 1 4,334 2,540 2,968
P/E ratio 651 x 65.6 x 50.7 x
Yield - 0.69% 0.7%
Capitalization / Revenue 1.28 x 0.7 x 0.68 x
EV / Revenue 1.27 x 0.64 x 0.67 x
EV / EBITDA 354 x 33.4 x 25.7 x
EV / FCF -21.5 x 14.3 x -15.8 x
FCF Yield -4.64% 6.99% -6.31%
Price to Book 5.63 x 3.39 x 3.56 x
Nbr of stocks (in thousands) 95,667 95,667 95,667
Reference price 2 45.55 28.86 31.45
Announcement Date 21/04/22 20/04/23 09/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,024 2,289 2,790 3,401 3,969 4,430
EBITDA 1 75.19 86.82 72.15 12.24 76.14 115.4
EBIT 1 71.27 78.4 62.51 0.0363 58.19 96.36
Operating Margin 3.52% 3.42% 2.24% 0% 1.47% 2.17%
Earnings before Tax (EBT) 1 67.86 74.87 61.83 8.124 44.89 69.88
Net income 1 56.56 64.66 54.02 6.4 42.02 59.53
Net margin 2.79% 2.82% 1.94% 0.19% 1.06% 1.34%
EPS 2 0.8200 0.9000 0.7500 0.0700 0.4400 0.6200
Free Cash Flow 1 -31.49 5.75 -0.9416 -201.2 177.6 -187.4
FCF margin -1.56% 0.25% -0.03% -5.92% 4.47% -4.23%
FCF Conversion (EBITDA) - 6.62% - - 233.18% -
FCF Conversion (Net income) - 8.89% - - 422.59% -
Dividend per Share - - 0.2000 - 0.2000 0.2200
Announcement Date 28/06/19 15/04/21 15/04/21 21/04/22 20/04/23 09/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 48.6 83.2 74.2 24 221 40.5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -31.5 5.75 -0.94 -201 178 -187
ROE (net income / shareholders' equity) 16% 13.8% 10.4% 1.02% 4.49% 6.77%
ROA (Net income/ Total Assets) 8.4% 7.11% 4.94% 0% 2.62% 3.67%
Assets 1 673.4 909.3 1,094 290,911 1,605 1,621
Book Value Per Share 2 5.730 6.630 7.220 8.090 8.510 8.830
Cash Flow per Share 2 1.360 1.720 1.590 1.610 4.790 3.880
Capex - 36.4 35.2 31.4 18.3 35.3
Capex / Sales - 1.59% 1.26% 0.92% 0.46% 0.8%
Announcement Date 28/06/19 15/04/21 15/04/21 21/04/22 20/04/23 08/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD. Stock Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.
-28.01% 302M
MCKESSON CORPORATION Stock McKesson Corporation
+21.93% 72.24B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+7.33% 8.92B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+10.34% 8.58B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-19.80% 8.07B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+14.16% 5.24B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+12.70% 4.24B
EBOS GROUP LIMITED Stock EBOS Group Limited
-0.03% 4.15B
GALENICA AG Stock Galenica AG
-2.54% 3.92B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+24.00% 3.75B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 300937 Stock
  4. Financials Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.